Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, has told DirectorsTalk that the two Coupled Cavity Linac modules are now ready for high-power testing at the Company’s facility in Geneva.
These two modules will be tested at high power by using the Radio Frequency (“RF”) Power Units provided by ScandiNova and Toshiba and it is the first time two CCL modules will be tested together. The finished LIGHT system will incorporate ten CCL units (15 CCL modules) in total and combined in a series will accelerate protons to the high energies required to treat radiosensitive tumours in a clinical setting.
Ensuring that the CCL units were ready for high-power testing was a key milestone in the Company’s timetable provided to shareholders in November 2014, and this marks another successful stage in the process of delivering the first working LIGHT system.
Commenting, Sanjeev Pandya, CEO of Advanced Oncotherapy, said: “The high-power testing of the components at this stage will be a crucial demonstration of their ability to perform to specifications. Initial low power testing has shown that they perform to expectations and we expect that the successful conclusion of these tests will give us confidence that the CCL modules can work under the required conditions to deliver the high energy protons that we need to treat patients effectively.”
